Dare Bioscience, Inc. (DARE)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch DARE
See up to 3 months of DARE. The 7-day demo opens the 1M and 3M ranges and puts DARE on your watchlist.
Start 7-day demoLatest DARE insider trades
Jessica D. Grossman - DirectorGrant or award26,066 sh
Susan L. Kelley - DirectorGrant or award23,696 sh
Gregory W. Matz
About Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. files with the SEC under CIK 0001401914 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site. A registration statement was filed on 26 August 2026. No offering has priced.
DARE Form 4 activity by transaction type, last 90 days
No Form 4 activity for DARE in the last 90 days.
DARE insider transactions (Form 4)
2019 Form 4 filings on record, the earliest from Jul 9, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jessica D. Grossman - Director | Grant or award | Common stock | 26,066 footnote F1 | $0.00 | - | |
| ||||||
| Susan L. Kelley - Director | Grant or award | Common stock | 23,696 footnote F1 | $0.00 | - | |
| ||||||
| Gregory W. Matz - Director | Grant or award | Common stock | 30,805 footnote F1 | $0.00 | - | |
| ||||||
 William H. Rastetter - Director | Grant or award | Common stock | 38,862 footnote F1 | $0.00 | - | |
| ||||||
 Robin Joan Steele - Director | Grant or award | Common stock | 26,540 footnote F1 | $0.00 | - | |
| ||||||
| William H. Rastetter - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Susan L. Kelley - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Robin Joan Steele - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Gregory W. Matz - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Jessica D. Grossman - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Sabrina Martucci Johnson - Officer | Grant or award | Series A Convertible Preferred Stock | 10,800 | - footnote F4 | - | |
| Sabrina Martucci Johnson - Officer | Grant or award | Common Stock Warrant (right to buy) | 21,600 | - footnote F4 | - | |
| ||||||
| Sabrina Martucci Johnson - Officer | Grant or award | Employee Stock Option (right to buy) | 172,000 | $0.00 | - | |
 Mardee Haring-Layton - Officer | Grant or award | Employee Stock Option (right to buy) | 49,000 | $0.00 | - | |
| Mardee Haring-Layton - Officer | Grant or award | Employee Stock Option (right to buy) | 57,000 | $0.00 | - | |
| Gregory W. Matz - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| Jessica D. Grossman - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| Susan L. Kelley - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| Robin Joan Steele - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| William H. Rastetter - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
Item 3.01
Item 7.01, 9.01
Item 5.03
Item 7.01, 9.01
DARE insider trading FAQ
What is the latest insider trade for DARE?
Dare Bioscience, Inc. (DARE) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-02. The full record for DARE runs to 19 Form 4 filings, the earliest from 2025-07-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DARE stock?
No insider purchases of DARE were filed in the last 90 days.
How many insiders are selling DARE stock?
No insider sales of DARE were filed in the last 90 days.
Where can I see DARE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DARE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jessica D. Grossman view on EDGAR
- - Susan L. Kelley view on EDGAR
- - Gregory W. Matz view on EDGAR
- - William H. Rastetter view on EDGAR
- - Robin Joan Steele view on EDGAR
- - William H. Rastetter view on EDGAR
- - Susan L. Kelley view on EDGAR
- - Robin Joan Steele view on EDGAR
- - Gregory W. Matz view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DARE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DARE with a 7-day demo
- DARE on your watchlist
- Every DARE Form 4 filing on record
- Up to 3 months of DARE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
